mEOC
Trial Description:
A GCIG Intergroup multicentre trial of open label carboplatin and paclitaxel +/- bevacizumab compared with oxaliplatin and capecitabine +/- bevacizumab as first line chemotherapy in patients with mucinous Epithelial Ovarian Cancer.
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Completed